André Gerth
Plus aucun poste en cours
Profil
André Gerth served as the Chief Executive Officer & IR Contact at Vita 34 AG from 2012 to 2017.
Prior to that, he was the Managing Director at BioPlanta GmbH from 1992 to 2012.
He also served as the Managing Director at stellacure GmbH.
Dr. Gerth holds a doctorate degree from Universität Leipzig.
Anciens postes connus de André Gerth
Sociétés | Poste | Fin |
---|---|---|
VITA 34 AG | Directeur Général | 12/06/2017 |
BioPlanta GmbH
BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Directeur Général | 01/07/2012 |
stellacure GmbH
stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Directeur Général | - |
Formation de André Gerth
Universität Leipzig | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VITA 34 AG | Health Technology |
Entreprise privées | 2 |
---|---|
BioPlanta GmbH
BioPlanta GmbH Pharmaceuticals: OtherHealth Technology Part of Active Ownership Capital SARL, BioPlanta GmbH is a German company that researches, develops, and distributes botanical active agents for pharmaceutical purposes. The company is based in Leipzig, Germany. BioPlanta was acquired by Vita 34 AG on May 16, 2012 for $1.47 million. | Health Technology |
stellacure GmbH
stellacure GmbH Medical/Nursing ServicesHealth Services stellacure GmbH provides cord blood and stem cell banking services. It specializes in the removal, processing, and deposit of stem cells from the umbilical cord blood. The firm also engages in partnerships with life sciences advisory firms and blood service units. The company was founded in 2006 and is headquartered in Leipzig, Germany. | Health Services |